SynaptixBio

Biotechnology Research • Oxford, England, United Kingdom • 1-10 Employees

Company overview

Headquarters	Oxford, England, United Kingdom
Phone number	+4413318389
Website	synaptixbio.com
NAICS	541714
Keywords	Pharmaceutical, Development, Biotech, Life Sciences, Neurology, Drug Discovery, Rare Disease, Brain, Leukodystrophy, Basal Ganglia, Cerebrllum, H-Abc, Hypomyelination, Paediatric Disorders, Preclincal
Founded	2021
Employees	1-10
Socials

Key Contacts at SynaptixBio

Dr Dan Williams

Chief Executive Officer

Michelle Teng

Founding Executive Director And Chief Scientific Advisor

SynaptixBio Email Formats

SynaptixBio uses 2 email formats. The most common is {first initial} (e.g., j@synaptixbio.com), used 50% of the time.

Format	Example	Percentage
{first initial}	j@synaptixbio.com	50%
{first name}	john@synaptixbio.com	50%

About SynaptixBio

Overview SynaptixBio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases. SynaptixBio’s mission is to deliver gene therapies for fatal leukodystrophies in children caused by loss of function or mutation in a single gene. Using a breadth of platforms including antisense oligonucleotide (ASO)-based technology, we can silence the expression of the toxic gene to reverse disease progression. This approach will create life saving treatments for severe genetic diseases that affect the central nervous system.

SynaptixBio revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	$3,210,400

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Head

Entry

Employees by Department

SynaptixBio has 5 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore SynaptixBio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-12-17	9	$610,400
2024-09-22	9	$2,600,000

Funding Insights

$3,210,400

Total funding amount

$2,600,000

Most recent funding amount

Number of funding rounds

SynaptixBio Tech Stack

Discover the technologies and tools that power SynaptixBio's digital infrastructure, from frameworks to analytics platforms.

Lodash

JavaScript libraries

Sentry

Issue trackers

Sirvoy

Appointment scheduling

WordPress.com

PaaS

Wix

Blogs

HTTP/3

Miscellaneous

PHP

Programming languages

Open Graph

Miscellaneous

HSTS

Security

React

JavaScript frameworks

WordPress

Blogs

Google Cloud

IaaS

Frequently asked questions

SynaptixBio is located in Oxford, England, GB.

You can reach SynaptixBio at +4413318389.

SynaptixBio was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

SynaptixBio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

SynaptixBio has raised a total of $3,210,400 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at SynaptixBio

Dr Dan Williams

Chief Executive Officer

Michelle Teng

Founding Executive Director And Chief Scientific Advisor

4.8

40,000 users